Literature DB >> 18191472

Assessing HRQL among Chinese patients with coronary heart disease: angina, myocardial infarction and heart failure.

Doris S F Yu1, David R Thompson, Cheuk-man Yu, Neil B Oldridge.   

Abstract

OBJECTIVE: To perform a psychometric evaluation of the Myocardial Infarction Dimensional Assessment Scale (MIDAS) in Chinese patients with coronary heart disease. DESIGN AND
SETTING: Patients with angina (n=162), MI (n=124) or heart failure (n=95) were recruited from a regional university-affiliated hospital. The Chinese version of the MIDAS (C-MIDAS), the Hospital Anxiety and Depression Scale (HADS) and the Short-Form 36 Health Survey (SF-36) were administered to all patients at baseline and the C-MIDAS was also administered seven day (n=92) and three months (n=363) later.
RESULTS: The C-MIDAS conforms to the 7-factor structure as proposed in the original version. It is reliable with Cronbach's alphas from 0.73 to 0.94 and test-retest reliabilities from 0.76 to 0.92. Four of its subscales (physical activity, insecurity, emotional reaction and dependency) correlated significantly with the SF-36 and the HADS in each diagnostic group and had good discriminative properties in terms of gender, emotional disturbance and perceived health deterioration, with responsiveness supported by medium-high effect sizes (0.43-0.83) and standardize response means (0.46-0.82). The other three subscales measuring treatment-related impacts added little to the validity and responsiveness of the C-MIDAS.
CONCLUSION: To render the C-MIDAS a core health-related quality of life measure for Chinese-speaking patients with coronary heart disease, further studies need to clarify the content adequacy and cultural relevancy of those subscales measuring treatment-related impact.

Entities:  

Mesh:

Year:  2008        PMID: 18191472     DOI: 10.1016/j.ijcard.2007.10.043

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  7 in total

Review 1.  The need for multicentre cardiovascular clinical trials in Asia.

Authors:  Joey S W Kwong; Cheuk-Man Yu
Journal:  Nat Rev Cardiol       Date:  2013-04-16       Impact factor: 32.419

2.  The palliative care in heart failure trial: rationale and design.

Authors:  Robert J Mentz; James A Tulsky; Bradi B Granger; Kevin J Anstrom; Patricia A Adams; Gwen C Dodson; Mona Fiuzat; Kimberly S Johnson; Chetan B Patel; Karen E Steinhauser; Donald H Taylor; Christopher M O'Connor; Joseph G Rogers
Journal:  Am Heart J       Date:  2014-07-30       Impact factor: 4.749

Review 3.  The bidirectional relation between psychiatric disorders with selected cardiovascular and endocrinal diseases: an Egyptian perspective.

Authors:  Tarek Okasha; Ash-Shayma Radwan
Journal:  Curr Psychiatry Rep       Date:  2015-01       Impact factor: 5.285

4.  Quality of life in women with coronary artery disease.

Authors:  Elham Ghasemi; Jaleh Mohammad Aliha; Farideh Bastani; Hamid Haghani; Niloufar Samiei
Journal:  Iran Red Crescent Med J       Date:  2014-07-05       Impact factor: 0.611

5.  Prevalence and Measurement of Anxiety in Samples of Patients With Heart Failure: Meta-analysis.

Authors:  Katherine Easton; Peter Coventry; Karina Lovell; Lesley-Anne Carter; Christi Deaton
Journal:  J Cardiovasc Nurs       Date:  2016 Jul-Aug       Impact factor: 2.083

6.  Quality of life in patients with coronary heart disease after myocardial infarction and with ischemic heart failure.

Authors:  Joanna M Moryś; Jerzy Bellwon; Stefan Höfer; Andrzej Rynkiewicz; Marcin Gruchała
Journal:  Arch Med Sci       Date:  2015-01-14       Impact factor: 3.318

7.  Health-Related Quality of Life Among Myocardial Infarction Survivors: Structural Equation Modeling Approach.

Authors:  Helen Lamesgin Endalew; Bikis Liyew; Tilahun Kassew; Gebrekidan Ewnetu Tarekegn; Ambaye Dejen Tilahun; Tesfa Sewunet Alamneh
Journal:  J Multidiscip Healthc       Date:  2021-06-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.